MétaCan
← tous les travaux

A Positive Feedback DNA-PK/MYT1L-CXCR1-ERK1/2 Proliferative Signaling Loop in Glioblastoma

2025· article· en· 1 citations· W4410105423 sur OpenAlex· 10.3390/ijms26094398

Pourquoi ce travail est-il dans la base ?

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

Affiliation canadienneUne personne signataire a déclaré un établissement canadien. C'est la seule voie dont dispose la base habituelle.
Organisme subventionnaire canadienUn organisme canadien l'a financé. Le travail peut ne porter aucune affiliation canadienne.

Le tri à trois modèles

les 1 000 travaux triés →

Les trois modèles l'ont jugé hors champ.

strate : aff_core · poids de sondage : 5595.24 (l'échantillon est stratifié ; tout taux calculé sans le poids est faux)
Claude Opus 4.8OUT
genre : empirical
porte sur le Canada: non
confiance: high

Molecular biology study of a proliferative signalling loop in glioblastoma.

GPT-5.6 (high)OUT
genre : empirical
porte sur le Canada: non
confiance: high

It investigates a glioblastoma signaling mechanism, not research methods or the research system.

Grok 4.5OUT
genre : empirical
porte sur le Canada: non
confiance: high

Molecular cancer biology of a DNA-PK/MYT1L signaling loop in glioblastoma, not research practice.

Résumé

Glioblastoma is the most common primary brain tumor in adults. Our previous studies revealed a functional interplay of myelin transcription factor 1-like (MYT1L) with the DNA-dependent protein kinase (DNA-PK) in the regulation of p21 transcription. However, the contributing role of this functional interplay in glioblastoma remains largely unknown. Here, we used cell lines with normal DNA-PK (HEK293 and M059K) or deficient DNA-PK (M059J) as a model system to demonstrate the importance of the DNA-PK-dependent activation of MYT1L in controlling the transcription of CXC chemokine receptor 1 (CXCR1) in a positive-feedback proliferative signaling loop in glioblastoma with numerous conventional techniques. In normal DNA-PK cells, MYT1L acted as an oncogene by promoting cell proliferation, inhibiting apoptosis, and shortening a cell cycle S phase. However, in DNA-PK-deficient cells, MYT1L functioned as a tumor suppressor by inhibiting cell proliferation and inducing a G1 arrest. The enforced expression of MYT1L promoted CXCR1 transcription in DNA-PK-normal cells but attenuated transcription in DNA-PK-deficient cells. Bioinformatics analysis predicted a MYT1L-binding sequence at the CXCR1 promoter. The functional dependence of MYT1L on DNA-PK in CXCR1 transcription was validated by luciferase assay. Although the expression of CXCR1 was lower in M059J cells as compared to M059K cells, it was higher than in normal brain tissue. The CXCR1 ligands interleukin 8 (IL-8) and GRO protein alpha (GROα) expressed in M059J and M059K cells may signal through the extracellular signal-regulated kinase 1/2 (ERK1/2) pathway that can be blocked by CXCR1 siRNA. Our findings demonstrate the existence of a positive feedback DNA-PK/MYT1L-CXCR1-ERK1/2 proliferation loop in glioblastoma cells that may represent a pharmacological target loop for therapeutic intervention.

Conservé avec la notice de tri, où il sert de preuve aux étiquettes ci-dessus.

La notice

Revue
International Journal of Molecular Sciences
Thématique
interferon and immune responses
Domaine
Immunology and Microbiology
Établissements canadiens
University of Lethbridge
Organismes subventionnaires
Canadian Institutes of Health Research
Mots-clés
BiologyCell cycleMolecular biologyTranscription factorCell growthSignal transductionCell biologyTranscription (linguistics)Cancer researchCellGeneBiochemistry
Résumé présent dans OpenAlex
oui